Handelsbanken Fonder’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.16M | Buy |
|
|||||
|
2025
Q2 | $9.12M | Sell |
|
|||||
|
2025
Q1 | $13.5M | Sell |
|
|||||
|
2024
Q4 | $11.7M | Sell |
|
|||||
|
2024
Q3 | $20.4M | Buy |
|
|||||
|
2024
Q2 | $18.9M | Buy |
|
|||||
|
2024
Q1 | $20.7M | Sell |
|
|||||
|
2023
Q4 | $25.1M | Sell |
|
|||||
|
2023
Q3 | $25.3M | Buy |
|
|||||
|
2023
Q2 | $24.3M | Buy |
|
|||||
|
2023
Q1 | $25.4M | Buy |
|
|||||
|
2022
Q4 | $24.1M | Buy |
|
|||||
|
2022
Q3 | $5.58M | Buy |
|
|||||
|
2022
Q2 | $2.07M | Buy |
|
|||||
|
2022
Q1 | $1.66M | Buy |
|
|||||
|
2021
Q4 | $1.35M | Hold |
|
|||||
|
2021
Q3 | $1.22M | Buy |
|
|||||
|
2021
Q2 | $459K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $408K | Buy |
|